Contract manufacturers in the life sciences face unprecedented complexity. Learn how CDMOs can transform operations for agility, speed and quality—mastering multi-product facilities and rapid changeovers while maintaining compliance in high-mix environments.
The digital divide between systems is costing you 70% of your manufacturing lead time. When ERP, MES, LIMS, and QMS systems can't talk to each other, operators become data entry clerks and errors multiply. See how leading manufacturers are connecting these systems to achieve 75% faster batch release and 90% fewer errors.
ICH E6(R3) is here, and it's game-changing for cell and gene therapy developers. With only 5%-10% of needed manufacturing capacity available, this principle-based guidance emphasizes risk management and digital tools that align perfectly with modern CGT operations. Companies implementing these approaches are seeing 75%-80% faster batch releases and 90% fewer errors. Find out why that changes everything.
Only 9% of life sciences professionals understand AI regulations, yet this technology could add $100 billion in industry value. With PCCPs merely the starting point, quality teams need comprehensive documentation strategies for FDA and EU AI Act compliance in 2025. Learn the five critical requirements to transform regulatory uncertainty into competitive advantage.
When data disconnects, opportunities disappear. In life sciences manufacturing, paper processes and siloed systems aren't just inefficient—they're costly barriers to innovation. Discover how collecting, connecting and contextualizing your manufacturing data can eliminate errors, accelerate compliance, and transform production metrics. Ready to digitize batch records and shatter throughput records?
Life sciences companies are revolutionizing QMS deployment with purpose-built solutions that slash validation effort by 70% and accelerate implementation by 50%. Discover how modern approaches deliver 90-day QMS implementation versus the 12-18 months it takes with traditional systems. That means you can get faster compliance, reduced costs, and quicker time to market—without compromising quality or regulatory standards.
Nearly two-thirds of manufacturers have embraced IoT technologies, with CDMOs leading adoption. Why? Modern regulatory frameworks demand modern tools. Paper processes create compliance vulnerabilities; digital solutions deliver competitive advantages. As MasterControl's research reveals, digital transformation has evolved from aspirational to existential for today's contract manufacturers.
Every minute spent reviewing batches is a minute patients wait for life-saving therapies. With quality testing consuming 70% of cell and gene therapy (CGT) manufacturing lead time, digital transformation is no longer optional—it's essential. Discover five proven strategies that slash CGT batch review times by 75% while maintaining compliance, helping you deliver therapies right first time, right on time.
Traditional MES validation can consume 104-plus hours of labor-intensive work. But what if validation became your competitive edge? Modern risk-based approaches slash validation time from months to hours while strengthening compliance. Discover how next-generation MES solutions are helping life sciences manufacturers implement faster, validate smarter, and bring life-changing products to patients sooner.
Discover how contract manufacturers are standardizing cell and gene therapy production to meet explosive demand (projected to hit $106B by 2033). Learn the digital strategies that are transforming individualized medicine from a complex challenge to a scalable reality.
Selecting a QMS? Don't overlook validation. For emerging life sciences manufacturers, this hidden burden can drain resources or compromise compliance. Pre-validated or custom approach? The answer depends on your company's stage, compliance needs, and growth trajectory. Learn how to make validation work for you—not against you.
Drowning in paperwork? You're not alone. With 70% of FDA warning letters citing data integrity issues, paper-based batch records create serious compliance risks. Digital transformation changes everything—reducing review time, eliminating errors, and ensuring ALCOA compliance. Discover how leading manufacturers are ditching paper for digital efficiency that accelerates time to market.
Discover how Thermo Fisher Scientific unified quality management across 700-plus sites and 80,000 employees through digital transformation. Their journey from fragmented systems to enterprise-wide integration showcases how cloud-based solutions can eliminate data silos and transform life sciences compliance. Their novel approach changes everything—and might just revolutionize your quality ecosystem, too.
Quality at the source isn't just a concept—it's the difference between life and death in cell and gene therapy manufacturing. With digital solutions slashing review times by 75% and cutting deviations by 25%, paper-based processes are becoming obsolete. Discover how modern CGT manufacturers are transforming quality from bottleneck to breakthrough.
Only 9% of life sciences pros understand AI regulations. That's a problem. MasterControl's Regulatory Chat bridges this gap with instant, AI-powered regulatory intelligence. No more document hunting. No more compliance headaches. Just smart, streamlined quality management that transforms SOPs, audits, and training.
Data integrity violations trigger 70% of FDA warning letters—and they’re often due to disconnected systems. By integrating your MES, QMS, and ERP platforms like SAP and NetSuite, you can eliminate paper-based inefficiencies, meet FDA requirements, and accelerate product releases. Discover how smart integration approaches can transform your operations, enhance data integrity, and keep you audit-ready.
For contract manufacturers, compliance isn't just a requirement—it's a dealmaker. Top CDMOs are leveraging digital maturity to transform regulatory readiness into competitive advantage. Discover how six evolving frameworks are reshaping sponsor expectations and why paperless operations aren't just about efficiency—they're your pathway to winning more contracts in an increasingly digital landscape.
With only 5%-10% of the needed manufacturing capacity available, cell and gene therapy (CGT) innovators face a critical challenge. Digital solutions can transform patient cells into life-saving treatments without sacrificing compliance or speed. Discover how your organization can eliminate paper, connect processes, and build quality into every step.
Eliminating 81% of manual data entries through automation isn't just a statistic—it's a revolution for life sciences manufacturers. Discover how smart automation strategies slash review times by 90%, increase throughput by 31%, and prevent millions of errors. Ready to transform paper-based frustration into digital manufacturing excellence? This is your roadmap to results that matter.
Traditional GMP approaches aren't built for the personalized medicine reality of cell and gene therapy development. With batch records spanning thousands of pages and 40% of executives doubting their scaling capabilities, digital transformation isn’t optional anymore—it's essential. Discover how leading manufacturers cut batch review time by 75% while strengthening compliance.
